Findings Could Lead to Early Diagnosis, Better Treatment Studies
An ultrasensitive test has been developed that detects a corrupted protein associated with Alzheimer’s disease and chronic traumatic encephalopathy (CTE), a condition found in athletes, military veterans, and others with a history of repetitive brain trauma. This advance could lead to early diagnosis of these conditions and open new research into how they originate, according to National Institutes of Health scientists and their colleagues. In their new study, published in Acta Neuropathologica, the researchers explain how they adapted a diagnostic test originally developed for prion diseases to detect abnormal clusters of tau protein. Like other proteins involved in neurological diseases, tau protein clusters can seed themselves and contribute substantially to the disease processes of Alzheimer’s and CTE. The study involved brain samples from 16 Alzheimer’s patients, two boxers with CTE, and numerous control cases involving other brain diseases.
The test is extremely sensitive. For example, if a pinhead-sized sample of brain tissue from an Alzheimer’s patient were pulverized and diluted into a thousand gallons of liquid, the test still could detect tau seeds in a pinhead-sized volume of that dilution. The test is called AD RT-QuIC: Alzheimer’s disease real-time quaking induced conversion.
Scientists at NIH’s National Institute of Allergy and Infectious Diseases developed RT-QuIC about a decade ago to detect Creutzfeldt-Jakob (CJD) and other prion diseases. Since then, they have repeatedly improved and adapted it to detect other neurological diseases, such as Parkinson’s and dementia with Lewy bodies. The test, which already is used in clinical settings to diagnose sporadic CJD, is noted for its rapid and accurate results.
Their latest findings could be a major advance for Alzheimer’s diagnostics because the study points to tau seeds as potential biological “markers” for Alzheimer’s disease in the brain. Scientists are testing therapies to slow the accumulation of tau clusters and the progression of neurological disease. In these efforts, they need more sensitive and accurate tests to better select clinical trial participants and assess whether new therapeutic strategies work as hoped.
Alzheimer’s affects about 5.7 million people in the United States alone at an estimated annual cost of $232 billion, according to the Alzheimer’s Association.
The Latest on: Alzheimer’s
via Google News
The Latest on: Alzheimer’s
- Update: Missing Alzheimer’s patient found at local hospital on February 19, 2019 at 2:38 pm
BURIEN, Wash. — The King County Sheriff’s Office is searching for an Alzheimer’s patient who has been missing since Sunday. According to the sheriff’s office, Robin McDougall, 64, was last ... […]
- Cindy Persky & Dr. Carolyn Nemec- The Women’s Alzheimer’s Movement Presents Their “Boost Your Brain” Event! on February 19, 2019 at 1:13 pm
Women are at the epicenter of the Alzheimer’s crisis. But there are things we can be doing to better our chances of not getting this dreaded disease. However, we need to raise more money for research, ... […]
- Local Alzheimer's advocates push for continued state help on February 19, 2019 at 1:11 pm
MADISON, Wis. - Tuesday is 2019 Alzheimer’s Advocacy Day. The disease is the sixth leading cause of death in Wisconsin and the United States. More than 200 advocates are attending legislative meetings ... […]
- 'Young blood' Alzheimer's treatments slapped with warning by FDA commissioner on February 19, 2019 at 11:54 am
Treatments offering to combat dementia and other Alzheimer's Disease-related conditions with infusions of blood from young donors were slapped Tuesday by the Food and Drug Administration, prompting at ... […]
- Charlottesville Church to Host Conference on Alzheimer's Disease on February 19, 2019 at 7:26 am
Pilgrim Baptist Church in Charlottesville is getting ready to host a conference on Alzheimer's disease to raise awareness and help caregivers in the African-American community. Studies show African-Am... […]
- Tiny worm mimics key genetic risk for Alzheimer's on February 19, 2019 at 6:15 am
Researchers at The University of Alabama have shown a tiny worm can replicate genetic causes of Alzheimer's disease, expanding the breadth of preclinical models for the disease. "This is exciting ... […]
- Could a blood test predict Alzheimer's disease 16 years before symptoms? on February 19, 2019 at 3:04 am
Could a blood test diagnose Alzheimer's disease up to 16 years before a person begins showing symptoms? The chief executive at Lexington-based Quanterix Corp. believes so. Clinical trial data publishe... […]
- Learning to Cope: Stories of Alzheimer's patients at Luvida Memory Care on February 19, 2019 at 2:07 am
The latest numbers from the Alzheimer’s Association show that 5.7 million Americans suffer from Alzheimer’s disease. It’s a baffling, often frustrating condition, and can be incredibly hard to cope wi... […]
- This Hormone Could Protect Against Alzheimer's—Here's How to Get More of It on February 18, 2019 at 5:47 pm
Deaths from Alzheimer's disease have risen significantly in the past 20 years, according to the Centers for Disease Control and Prevention. This form of dementia strikes more than 5 million Americans, ... […]
- Calming Agitation in Alzheimer's Patients on February 18, 2019 at 1:29 pm
An estimated 5.7 million Americans are living with Alzheimer's disease. And that number is expected to grow to 14 million by the year 2050. So far, there is no cure, but scientists continue to look fo... […]
via Bing News